Biotechnology Anti-payload Antibodies: Facilitating ADC PK studies Sino Biological has successfully developed anti-payload antibodies which are used for analyzing the plasma/serum PK profiles, DAR values, and drug load distribution of ADC drugs. Anti-payload antibodies are used to evaluate the safety and efficacy of ADC drugs in the preclinical and clinical stages, empowering the ADC drug development process. As a great partner for […] Written by Arno Fricke August 31, 2024August 31, 2024 Saving Bookmark this article Bookmarked
Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders Copenhagen-based biotech Neumirna Therapeutics has secured €20 million in a Series A funding round co-led by Angelini Ventures and Invivo Partners, with participation from Innovestor’s Life Science Fund and existing investors. The funding will advance Neumirna’s pioneering RNA therapeutics pipeline, including its lead candidate NMT.001, an antisense oligonucleotide (ASO) therapy targeting drug-resistant epilepsy. Founded in […] Written by Anette Mertens January 12, 2025January 12, 2025 Saving Bookmark this article Bookmarked
Access Denied Access Denied You don’t have permission to access ” on this server. Reference #18.1d6d3e17.1736670171.27cd2a7 Written by Admin January 12, 2025January 12, 2025 Saving Bookmark this article Bookmarked
Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders Copenhagen-based biotech Neumirna Therapeutics has secured €20 million in a Series A funding round co-led by Angelini Ventures and Invivo Partners, with participation from Innovestor’s Life Science Fund and existing investors. The funding will advance Neumirna’s pioneering RNA therapeutics pipeline, including its lead candidate NMT.001, an antisense oligonucleotide (ASO) therapy targeting drug-resistant epilepsy. Founded in […] Written by Anette Mertens January 12, 2025January 12, 2025 Saving Bookmark this article Bookmarked
Access Denied Access Denied You don’t have permission to access ” on this server. Reference #18.1d6d3e17.1736670171.27cd2a7 Written by Admin January 12, 2025January 12, 2025 Saving Bookmark this article Bookmarked
Scientists Develop Bacteria-Repellent Surfaces That Promote Cell Growth image: The team have shown that their nanostructured surfaces resist the growth of bacteria, but enable the culturing of cells. view more Credit: Tokyo Metropolitan University Tokyo, Japan – Researchers from Tokyo Metropolitan University have created nanostructured alumina surfaces which are strongly antibacterial but can be used to culture cells. They found that anodic porous […] Written by Bioengineer January 12, 2025January 12, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked
